Biofeedback Gait Training for Diabetic Peripheral Neuropathy
Trial Summary
What is the purpose of this trial?
The purpose of this study is to 1) examine the differences in walking function and movement patterns between individuals with diabetic peripheral neuropathy and healthy adults with no known conditions; 2) examine if receiving feedback on walking form will help change walking patterns; and 3) examine the feasibility, safety, and preliminary effects of walking training with feedback on walking function in individuals with diabetic peripheral neuropathy.
Do I have to stop taking my current medications to join the trial?
The trial protocol does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the idea that Biofeedback Gait Training for Diabetic Peripheral Neuropathy is an effective treatment?
The available research shows that Biofeedback Gait Training can help people with diabetic peripheral neuropathy by teaching them a new way to walk that reduces pressure on their feet. This is important because too much pressure can lead to foot ulcers, which are common in people with this condition. One study found that using biofeedback to learn a new walking strategy helped lower foot pressure to safer levels without creating new problem areas. Another study highlighted that biofeedback can improve walking patterns by using rhythmic cues, which helps people walk more evenly and with less effort. Overall, these studies suggest that Biofeedback Gait Training is a promising treatment for improving walking and reducing foot pressure in people with diabetic peripheral neuropathy.12345
What safety data exists for biofeedback gait training?
The research provided does not directly address safety data for biofeedback gait training. However, it suggests that biofeedback is used in various contexts, such as improving gait asymmetries, reducing ankle inversion, and enhancing propulsion in post-stroke individuals. These studies focus on the effectiveness and biomechanical outcomes rather than safety. For specific safety data, further research or clinical trial results would be needed.13678
Is Gait Biofeedback a promising treatment for people with diabetic peripheral neuropathy?
Yes, Gait Biofeedback is a promising treatment for people with diabetic peripheral neuropathy. It helps reduce foot pressure, which is important for healing and preventing foot ulcers. It also improves nerve function, muscle activation, and foot movement, making walking safer and more comfortable.1291011
Research Team
Nicole Rendos, PhD
Principal Investigator
Assistant Professor
Eligibility Criteria
This trial is for adults aged 45 and older with diabetic peripheral neuropathy (DPN) who can walk independently without aids. Participants must have a diabetes diagnosis, be able to walk on a treadmill, and have had a foot exam in the last six months. People with certain lower limb conditions, surgeries affecting walking, cardiovascular issues that impact safety while walking, or those pregnant cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Initial Evaluation and Baseline Testing
Participants undergo clinical evaluation, gait biomechanics, and gait biofeedback for baseline comparison
Biofeedback Gait Training
Participants with DPN receive biofeedback gait training focusing on plantar pressure and propulsion
Follow-up
Participants are monitored for changes in biomechanics and propulsion after training
Treatment Details
Interventions
- Gait Biofeedback
- Plantar Pressure Biofeedback Gait Training
- Propulsion Biofeedback Gait Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emory University
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator